4 ms·
Japan's superior alternative to Paxlovid called Xocova, finally available in US
- ck2 2mo agoprevious coverage before it was approved, explaining the superiority * https://www.theatlantic.com/health/archive/2023/10/xocova-ensitrelvir-covid-antiviral/675768/ https://www.theatlantic.com/health/archive/2023/10/xocova-en... * https://nypost.com/2023/10/26/health/why-covid-sufferers-in-the-us-cant-get-ensitrelvir-the-antiviral-drug-better-than-paxlovid/ https://nypost.com/2023/10/26/health/why-covid-sufferers-in-... Differences in Treatment Patterns and Patient Characteristics Between COVID-19 Patients Treated with Nirmatrelvir/Ritonavir and Ensitrelvir in Japan * https://pmc.ncbi.nlm.nih.gov/articles/PMC11345459/ https://pmc.ncbi.nlm.nih.gov/articles/PMC11345459/